AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2018
May 16, 2018
29828_dirs_2018-05-16_339c9cd3-e244-4651-bb6d-ef3d486f8469.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-05-09
Reporting Person: Pletcher Brett A (EVP, Gen Counsel & Corp Sec)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18941 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) | $24.905 | 2019-07-29 | Common Stock (7200) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $16.89 | 2020-07-22 | Common Stock (2400) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $24.295 | 2022-01-26 | Common Stock (35400) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $40.56 | 2023-02-01 | Common Stock (32560) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $80.65 | 2024-02-01 | Common Stock (25780) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $104.83 | 2025-02-01 | Common Stock (23460) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $116.58 | 2025-08-10 | Common Stock (14830) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $84.05 | 2026-02-01 | Common Stock (53590) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $72.25 | 2027-02-02 | Common Stock (73480) | Direct | |
| Non-qualified Stock Option (Right to Buy) | $83.49 | 2028-02-01 | Common Stock (69200) | Direct | |
| Restricted Stock Unit | $ | Common Stock (4140) | Direct |
Footnotes
F1: The shares subject to the option have a five-year vesting schedule. 20% vest on the first anniversary of the date of the grant. The balance will vest 5% quarterly thereafter until fully vested.
F2: The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3: The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F4: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.